Palatin Technologies Inc (PTN)
0.9385
+0.02
(+2.66%)
USD |
NYAM |
Nov 21, 16:00
0.91
-0.03
(-3.04%)
After-Hours: 20:00
Palatin Technologies Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 95.20% |
September 30, 2023 | |
June 30, 2023 | 94.10% |
March 31, 2023 | 89.19% |
December 31, 2022 | 90.38% |
September 30, 2022 | 90.05% |
June 30, 2022 | 88.64% |
March 31, 2022 | 78.29% |
December 31, 2021 | 90.94% |
September 30, 2021 | 66.18% |
June 30, 2021 | 78.42% |
March 31, 2021 | 37.53% |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
37.53%
Minimum
Mar 2021
95.20%
Maximum
Dec 2023
81.72%
Average
89.19%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 65.26% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Nanoviricides Inc | -- |